Figure 2.

Shown are Kaplan-Meier curves for OS. The tick marks indicate censored data, and the dashed vertical lines indicate the times of landmark analyses of OS.

OS in patients (A) with or (B) without^a stage IIIA-N2 NSCLC.

CI, confidence interval; DCO, data cut-off; HR, hazard ratio; NE, not estimable; NR, not reached; NSCLC, non-small-cell lung cancer; OS, overall survival.

^aPatients with all other stages (including stages IIIA-N0/N1 and IIIB). DCO = 22 March 2018 (DCO for the primary analysis of OS): median follow-up of 25.2 months (range: 0.2-43.1 months).